Brief: Carerx Reports Continued Strong Growth For Q3 Of 2022
Nov 9 (Reuters) - Carerx Corp CRRX.TO :
* CARERX REPORTS CONTINUED STRONG GROWTH FOR THE THIRD
QUARTER OF
2022
* Q3 REVENUE C$97.4 MILLION
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.04
Source text for Eikon: ID:nCNW0Y1H4a
Further company coverage: CRRX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024